Several reports described the regulation of Bcl-2 by miR-148a and identified it as one of its target proteins in colorectal cancer (Zhang et al., 2011), pancreatic cancer (Zhang et al., 2014) and breast cancer (Li et al., 2017). Here, BCL2 is linked to pancreatic neoplasm.